Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 650 of 2051 entries
View as:

Phase IIB 2-Period Crossover Polysomnography Study in Participants With Primary Insomnia (MK-4305-006)

Phase: N/A Priority: Normal
NCT ID: NCT00792298 Org: User:
Start: 11/05/08 End: 12/26/09 Due: 12/26/10

Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)

Phase: N/A Priority: Normal
NCT ID: NCT03158220 Org: User:
Start: 09/20/17 End: 11/19/18 Due: 11/19/19

Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008)

Phase: N/A Priority: Normal
NCT ID: NCT01919125 Org: User:
Start: 08/31/13 End: 02/28/14 Due: 02/28/15

Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006)

Phase: N/A Priority: Normal
NCT ID: NCT02547649 Org: User:
Start: 10/08/15 End: 01/20/16 Due: 01/20/17

A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)

Phase: N/A Priority: Normal
NCT ID: NCT00943371 Org: User:
Start: 08/31/07 End: 05/31/09 Due: 05/31/10

A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00551187 Org: User:
Start: 10/31/07 End: 05/31/09 Due: 05/31/10

The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period

Phase: N/A Priority: Normal
NCT ID: NCT00892970 Org: User:
Start: 04/30/09 End: 01/31/10 Due: 01/31/11

A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00704054 Org: User:
Start: 01/31/08 End: 06/30/10 Due: 06/30/11

Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)

Phase: N/A Priority: Normal
NCT ID: NCT00617123 Org: User:
Start: 07/01/08 End: 10/01/10 Due: 10/01/11

Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)

Phase: N/A Priority: Normal
NCT ID: NCT00687323 Org: User:
Start: 07/30/07 End: 12/23/12 Due: 12/23/13

Pharmacodynamic and Pharmacokinetic Variability of a Basal Insulin (0000-168)

Phase: N/A Priority: Normal
NCT ID: NCT01152242 Org: User:
Start: 08/31/10 End: 05/31/12 Due: 05/31/13

Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)

Phase: N/A Priority: Normal
NCT ID: NCT05224141 Org: User:
Start: 03/24/22 End: 06/07/27 Due: 06/07/28

A Clinical Study of MK-1084 With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Phase: N/A Priority: Normal
NCT ID: NCT06997497 Org: User:
Start: 07/17/25 End: 06/29/31 Due: 06/29/32

A Clinical Study of Efinopegdutide (MK-6024) in Healthy Chinese Volunteers (MK-6024-011)

Phase: N/A Priority: Normal
NCT ID: NCT06836037 Org: User:
Start: 09/05/22 End: 02/02/23 Due: 02/02/24

A Study of Oral Suberoylanilide Hydroxamic Acid (Vorinostat) in Patients With Solid Tumors (0683-048)

Phase: N/A Priority: Normal
NCT ID: NCT00373490 Org: User:
Start: 07/31/06 End: 10/31/07 Due: 10/31/08

Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032)

Phase: N/A Priority: Normal
NCT ID: NCT01293006 Org: User:
Start: 03/25/11 End: 02/22/12 Due: 02/22/13

Observational Study to Evaluate the Current Neuromuscular Monitoring Practice Used After Different Types of Surgery, for Which Neuromuscular Blocking Agents Were Used, With or Without Blocking Reversal (P06556)

Phase: N/A Priority: Normal
NCT ID: NCT01213264 Org: User:
Start: 09/30/10 End: 02/29/12 Due: 02/28/13

A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)

Phase: N/A Priority: Normal
NCT ID: NCT01235728 Org: User:
Start: 11/01/10 End: 04/01/11 Due: 04/01/12

A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)

Phase: N/A Priority: Normal
NCT ID: NCT00741104 Org: User:
Start: 01/31/08 End: 06/30/08 Due: 06/30/09

V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)

Phase: N/A Priority: Normal
NCT ID: NCT01544478 Org: User:
Start: 11/25/11 End: 08/27/16 Due: 08/27/17

Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00935259 Org: User:
Start: 07/31/09 End: 10/31/09 Due: 10/31/10

Pharmacokinetics of MK-3682B in Participants With Moderate to Severe Renal Insufficiency (MK-3682B-030)

Phase: N/A Priority: Normal
NCT ID: NCT02661126 Org: User:
Start: 01/19/16 End: 08/26/16 Due: 08/26/17

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Phase: N/A Priority: Normal
NCT ID: NCT03486873 Org: User:
Start: 08/21/18 End: 08/04/43 Due: 08/04/44

A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030)

Phase: N/A Priority: Normal
NCT ID: NCT00127140 Org: User:
Start: 06/30/05 End: 04/30/12 Due: 04/30/13

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children With Sickle Cell Disease (V114-023/PNEU-SICKLE)

Phase: N/A Priority: Normal
NCT ID: NCT03731182 Org: User:
Start: 01/23/19 End: 06/08/20 Due: 06/08/21